骨誘導因子(OGN)多克隆抗體
Polyclonal Antibody to Osteoglycin (OGN)
OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor
- 編號PAC688Mu01
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPC688Mu01-骨誘導因子(OGN)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度0.28mg/ml
- 且適物種Rattus norvegicus (Rat,大鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 648 ¥ 1512 ¥ 2160 ¥ 5400 ¥ 21600
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
特異性
該抗體是針對OGN的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別OGN。
用法
Western blotting: 0.5-2μg/mL;1:140-550
Immunohistochemistry: 5-20μg/mL;1:14-55
Immunocytochemistry: 5-20μg/mL;1:14-55
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應用(僅供研究使用,不用于臨床診斷!) |
RPC688Mu02 | 骨誘導因子(OGN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC688Mu01 | 骨誘導因子(OGN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC688Mu01 | 骨誘導因子(OGN)多克隆抗體 | WB; IHC; ICC; IP. |
PAC688Mu02 | 骨誘導因子(OGN)多克隆抗體 | WB; IHC; ICC; IP. |
LAC688Mu71 | 骨誘導因子(OGN)多克隆抗體(生物素標記) | WB; IHC; ICC. |
SEC688Mu | 骨誘導因子(OGN)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC688Mu | 骨誘導因子(OGN)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Bone. | Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. [pubmed:27836731] |
Tohoku journal of experimental medicine | Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. [pubmed:28824047] |
Molecular Metabolism | Osteoglycin, a novel coordinator of bone and glucose homeostasis [Pubmed:29799418] |
Journal of Experimental &?Clinical?Cancer?Research | Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway [Pubmed:29499765] |
Journal of Human Hypertension | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients [Pubmed:29867136] |
Cell?Reports | Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue [Pubmed: 30332637] |
J Clin Endocrinol Metab | Osteoglycin across the adult lifespan [34850904] |
留言咨詢